Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Moderate quality score of 55/100, reflecting stable operating margins and manageable leverage.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Verdict: Average quality business weighed down by significant growth concerns.
Wall Street is cautious, forecasting potential downside alongside robust expected earnings growth. This outlook is strongly supported by highly attractive capital returns, driven predominantly by aggressive share repurchases.
Returns capital exclusively via buybacks — no active dividend
TZOO demonstrates strong business quality with robust profitability and healthy margins. This is paired with a moderately leveraged but stable balance sheet.
The company demonstrates solid revenue growth (9.1% 3Y CAGR) however, earnings have severely contracted over the same period. Operating efficiency remains adequate with margins around 7.1%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $24.3M | +9.3% | +9.1% | +11.3% | -4.3% | |
| EBITDA | $3.4M | — | -9.6% | — | — | |
| Net Income | $2.5M | -65.3% | -10.9% | — | -8.0% | |
| EPS (Diluted) | $0.23 | -61.3% | -8.2% | — | -5.7% | |
| Free Cash Flow | $3.8M | -73.3% | — | -34.6% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 79.4% | 85.0% | 84.5% | 85.8% |
| Operating Margin | 7.1% | 16.0% | 11.3% | 6.7% |
| Net Margin | 4.3% | 12.0% | 9.4% | 3.8% |
| FCF Margin | 6.7% | 14.5% | -0.9% | 10.5% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.16 | $0.23 | +43.8% | ||
| Q1'26 | $0.11 | $0.26 | +136.4% | ||
| Q4'25 | $0.14 | $0.01 | -92.9% | ||
| Q3'25 | $0.23 | $0.12 | -47.8% | ||
| Q2'25 | $0.25 | $0.25 | +0.0% | ||
| Q1'25 | $0.26 | $0.26 | +0.0% | ||
| Q4'24 | $0.20 | $0.26 | +30.0% | ||
| Q3'24 | $0.22 | $0.23 | +4.5% |
Total return is -12.5% (1Y), lagging the benchmark by -37.5%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +58.2% | +48.8% | — |
| 1Y | -12.5% | -37.5% | — |
| 3YCAGR | +5.7% | -15.0% | — |
| 5YCAGR | -6.3% | -19.0% | — |
| 10YCAGR | +3.1% | -11.1% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Travelzoo (TZOO) valuation, health, and returns.
Based on peer relative multiples, Travelzoo appears Slightly expensive versus peers compared to industry peers.
Travelzoo has multiple valuation anchors: Peer Relative Fair Value: $8.82 | Wall Street Analyst Target: $10.00 (implying -8.8% upside). A convergence of these signals offers higher conviction.
Travelzoo displays fair financial health with a composite quality score of 55/100, supported by a Altman Z-Score of 3.7 (safe zone), Piotroski F-Score of 5/9.
Travelzoo returns capital via buybacks instead of dividends, carrying a 10.9% buyback yield and reducing outstanding shares by -10.7% in the last 12 months.
Travelzoo's current growth trajectory is Stable. The company achieved +9.3% 1Y revenue growth and -61.3% 1Y EPS growth, compared to its 3Y revenue CAGR of +9.1%.
Wall Street consensus is Buy based on 5 analysts, beating EPS expectations in 58% of recent quarters with a 2-quarter streak. The consensus price target represents a -8.8% change from current levels.
Investment risks for Travelzoo include: -63.8% 1-year max drawdown. Volatility risk is characterized by a beta of 1.28x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.